LMCE2023

[SY12]
Edutrack (Education Session in Laboratory Medicine; 전공의 및 신임전문의 교육)​

This session aims to learn essential contents in the field of laboratory medicine for residents and new specialists.

[SY13]
The Supply Side of Laboratory Medicine​

The registration and licensing systems of devices and reagents for medical use including the clinical laboratory can vary among different countries. Sharing information on the manufacture, distribution, contract methods (purchase/lease), and market size of products (imported/domestic) used in laboratory medicine in each country can help us understand how the system works in different areas and also provide new ideas to better assess and potentially improve our own systems. In this session, we will explore the supply side of laboratory medicine from nine different countries in Asia to address the administrative challenges we face in each jurisdiction.

[PL03]
Plenary Lecture 03​

[KS03]
Keynote Speech 03​

[SY14]
MFDS-KSLM Joint Session: Performance Evaluation and Value up for IVD

To foster the growth of the domestic in vitro diagnostic (IVD) industry and enhance the utilization of IVD tests, it is imperative to prioritize accurate performance evaluation and verification. These measures play a pivotal role in elevating the overall worth of IVD. To facilitate this mission, the External Affairs Committee has orchestrated a collaborative symposium. This symposium will bring together key stakeholders, including the Ministry of Food and Drug Safety, IVD companies, and laboratory medicine experts. The primary agenda of this event is to engage in discussions pertaining to post-approval evaluation and the documentation of clinical performance assessments. These deliberations aim to further augment the value and reliability of IVD devices within the medical field.

[SY15-A]
KDCA-KSLM

During the COVID-19 pandemic, the Korean Society for Laboratory Medicine (KSLM) and the Korea Disease Control and Prevention Agency (KDCA) collaborated closely to successfully enhance their initial diagnostic testing capacity for COVID-19. They played a leading role in the prevention and control of COVID-19 until the development of vaccines and therapeutics. Building on this foundation, it is crucial to examine the continuous collaboration between the KSLM and KDCA for future responses to infectious diseases and chronic diseases.

[SY15-B]

We are delighted to present a collaborative effort between the Korean Society of Clinical Laboratory Medicine and the Korea Disease Control and Prevention Agency (KCDC) as we organize the Standardization Symposium. This symposium is dedicated to showcasing ongoing activities in chronic disease diagnostics and laboratory medicine standardization, providing valuable insights from both domestic and international perspectives. Additionally, our symposium underscores our commitment to enhancing diagnostic accuracy, ensuring consistency, and facilitating the exchange of critical patient information in the field of chronic disease diagnostics. With a shared vision to improve quality and patient safety, our goal is to promote collaboration among institutions and experts, driving advancements in clinical laboratory medicine.

[SY16]
Fungal infection, from clinical review to new immunological tests​

As the importance of fungal infection increases due to the increase in various tumors and immunosuppressed patients, treatment through rapid and sensitive diagnosis is required. In this session, we will learn from clinical experience to new fungal diagnosis methods.

[SY17]
Current status and future directions of laboratory information system​

In this session, we will introduce the current status of laboratory information system (LIS) and discuss the functions that will be helpful for laboratory practice if included in the future LIS.

[SY18]
Preparedness and surveillance for emerging and re-emerging infectious diseases

In this session, we will discuss how to monitor and prepare for emerging and re-emerging infectious diseases in post-covid period.